Trial Profile
The Effect of Rsedronate and Denosumab on Periprosthetic Bone Remodeling Following Total Hip Arthroplasty
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Dec 2020
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Risedronic acid
- Indications Osteoarthritis
- Focus Therapeutic Use
- 22 Dec 2020 Status changed from active, no longer recruiting to completed.
- 07 May 2018 Status changed from recruiting to active, no longer recruiting.
- 21 Jun 2016 Status changed from not yet recruiting to recruiting.